Navigation Links
American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Date:4/6/2012

NEWARK, N.J., April 6, 2012 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB) (the "Company") today announced that the New York Stock Exchange (the "NYSE") has notified the Company that it is not in compliance with NYSE rules due to the Company's failure to timely file its Annual Report on Form 10-K with the Securities and Exchange Commission.

Under NYSE rules, when a Company does not comply with annual report filing requirements, the NYSE allows a company an additional six months to file its annual report in order to regain compliance.  In the case of the Company, the annual report would be due on or before October 29, 2012.  If the Company fails to file its annual report within that time period, the NYSE may, in its sole discretion, allow the Company's securities to remain listed for up to an additional six months or may, in its sole discretion, commence suspension and delisting procedures. 

As previously announced, during the performance of the annual audit of the Company's financial statements for the fiscal year 2011, the Company's auditors, Ernst & Young Hua Ming's (E&Y), noted certain inconsistencies.  As a result, the Audit Committee has commenced an independent investigation into the matters identified by E&Y.  Although the Company cannot know at this time how long the investigation will take, the Company will endeavor to file the Form 10-K as soon as possible upon the completion of the investigation.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products. 

Safe Harbor Statement

Statements made in this press release are forward-looking an
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
2. American Association for Homecare Applauds Efforts to Eliminate Fraud in Medicare
3. Medicare Bidding Program Endangers Patients, Costs Jobs in Pittsburgh, says American Association for Homecare
4. Endo Announces Departure of American Medical Systems President
5. American Foundation for the Blind Announces 2012 Access Award Winners
6. Quest International Donates $5000 to the American Cancer Society
7. Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder
8. Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight
9. Johnson & Johnson to Provide Webcast Presentation of XARELTO® (rivaroxaban) Phase 3 Clinical Data Presented at the American College of Cardiologys Annual Scientific Sessions
10. Nile Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting
11. The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today announced validation ... Marketing Authorization Application (MAA) for sebelipase alfa for ... request for accelerated assessment, which has the potential ... The MAA, and the Biologics License ...
(Date:12/24/2014)... China , Dec. 23, 2014 ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today announced that the Company ... its Good Manufacturing Practice (GMP) certificate of TPI,s ... Drug Administration,s (CFDA). The public notice period is ...
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), ... CytoSorb® blood purification technology to help fight deadly ... 28 countries worldwide, today announced the appointment of ... FACS, as its Senior Vice President of Clinical ... Dr. Di Russo is an accomplished ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
(Date:12/24/2014)... December 24, 2014 Connie Casad, MD, ... functional medicine advocate with 30 years of practice experience ... evaluate the health benefits of dietary detoxification. The second ... participants following excellent results from test patients who just ... to explain her interest in conducting the study, Dr. ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Risperdal lawsuit ... a mass tort litigation currently underway in Pennsylvania’s Philadelphia ... As of December 24, 2014, court documents indicate that ... behalf of individuals who developed gynecomastia (male breast growth) ... from the Court indicates that this represents an increase ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... Today, UWDress.com, the famous women’s dress supplier, ... and launched a site-wide wedding gown promotion. , ... in a more unexpected way, the collection should be a ... the global market, and they are available with custom service. ... at discounted prices, up to 75% off; most of them ...
(Date:12/24/2014)... The report “Stivarga (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... which is used in the treatment of colon or ... also prescribed to patients who suffer from advanced gastrointestinal ... a multi-kinase inhibitor and it blocks many enzymes which ...
Breaking Medicine News(10 mins):Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... WASHINGTON, D.C.Exemplary work in genetic imaging and therapy have ... & Molecular Biology at Jefferson Medical College of Thomas ... at Jefferson, recognition by his peers as a 2010 ... Science (AAAS). AAAS is honoring Dr. Wickstrom for ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) ... attitude: The most optimistic adolescents may be somewhat less likely ... have found a slight link between optimism and less heavy ... new research, on kids in Australia, doesn,t prove that optimism ...
... a common problem for patients with schizophrenia. The increased tendency ... smoke, but to do so more heavily than the general ... acting as a treatment for some symptoms of schizophrenia. ... those with high and low affinity for nicotine. The low ...
... remains an unresolved issue as to whether interstitial brachytherapy has ... prostate cancer, nor do newer studies provide proof in this ... the Institute for Quality and Efficiency in Health Care (IQWiG) ... newer studies challenged the findings of research already completed in ...
... risk of an ectopic pregnancy because of a lasting effect ... the first time of how chlamydia can increase the risk ... implants outside the womb, in the Fallopian tube. Researchers ... had the sexually transmitted infection were more likely to produce ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) -- The ... on Saturday will likely cause some permanent damage, but experts ... be. However, doctors at University Medical Center in Tucson ... are already encouraged by her ability to follow simple instructions. ...
Cached Medicine News:Health News:Optimism Could Help Kids Keep Depression at Bay 2Health News:Targeting nicotine receptors to treat cognitive impairments in schizophrenia 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 4Health News:Wounded Congresswoman Responds to Simple Commands 2Health News:Wounded Congresswoman Responds to Simple Commands 3Health News:Wounded Congresswoman Responds to Simple Commands 4
... SYSCAN3® Hospital Test Kit is a multi-well ELISA ... in a standard serology laboratory without the need ... specific antigen preparation from Candida albicans. Our SYSCAN3 ... the presence of antibodies to Candida in the ...
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
... Health Record streamlines patient information management ... A flexible and easily customizable solution, ... financial benefits. HealthMatics EHR organizes communication ... and with outside practitioners. It also ...
... generation of advanced Electronic Medical Records (EMR) ... numerically codified medical vocabularies in the world. ... embedded in MedcomSoft Record, healthcare providers can ... and intuitive point and click system and ...
Medicine Products: